Surgical treatment of pterygium in melanoderma: Preliminary results of the conjunctival autograft at the infirmary of bamako hospital

Abstract

Pterygium is a benign eye disease with varying prevalence in different regions. Ultraviolet light is the main risk factor. The curative treatment is surgical, but it remains incompletely effective with recurrences that are not rare. Many techniques are described alone or combined with adjuvant treatments. The aim of our work is to evaluate the preliminary outcome of pterygial excision with conjunctival autograft.A prospective study was carried out between May 2016 and October 2017 in the ophthalmology department of the Bamako Hospital Infirmary. It included 81 patients who had a primary or recurrent pterygium operated on in the department.The average age was 45.74 years. The sex ratio was 1.13 M/F. Of the 81 pterygions operated on, 14.8% were stage IV and 16% recurrent, with nasal localization in 92.6%. Conjunctival hyperhaemia more or less associated with subconjunctival haemorrhage was present until postoperative day 15. We noted 4.9% recurrence.There is no consensus in the surgical treatment of pterygions. The technique of removal of the pterygium associated with conjunctival autograft would induce fewer complications and the least recurrence.Early management of pterygium with the autograft technique remains the best therapeutic choice for this condition.